androgenetic alopecia

Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.


loss of hair; baldness. The cause of simple baldness is not yet fully understood, although it is known that the tendency to become bald is limited almost entirely to males, runs in certain families, and is more common in certain racial groups than in others. Baldness is often associated with aging, but it can occur in younger men. minoxidil has been approved as a topical treatment for male pattern baldness. Approximately one-third of the men undergoing this therapy have experienced hair regrowth. The effects of the drug take several months to develop and new hair growth may be limited; the hair is lost if treatment is discontinued. Hair transplants are also available to selected patients. Many men opt for no treatment.

Alopecia as an outcome of chemotherapy for a malignancy can be very distressing. The loss of hair usually is temporary and the hair will grow back after the course of treatment is completed. Male patients may feel more comfortable wearing a hat or cap when out in public. Female patients who wish to wear a wig are encouraged to obtain one that is lightweight and the same color as their hair. Having a hairdresser cut the wig to the patient's usual hair style can increase self-esteem. A kerchief or head scarf can be worn around the house if it is more comfortable than a wig. Receipts for wigs, hairpieces, and other headcovering should be saved; they are tax-deductible medical expenses when related to chemotherapy.
androgenetic alopecia (alopecia androgene´tica) a progressive, diffuse, symmetric loss of scalp hair. In men it begins in the twenties or early thirties with hair loss from the crown and the frontal and temple regions, ultimately leaving only a sparse peripheral rim of scalp hair (male pattern alopecia or male pattern baldness). In females it begins later, with less severe hair loss in the front area of the scalp. In affected areas, the follicles produce finer and lighter terminal hairs until terminal hair production ceases, with lengthening of the anagen phase and shortening of the telogen phase of hair growth. The cause is unknown but is believed to be a combination of genetic factors and increased response of hair follicles to androgens.
alopecia area´ta hair loss in sharply defined areas, usually the scalp or beard.
alopecia ca´pitis tota´lis loss of all the hair from the scalp.
cicatricial alopecia (alopecia cicatrisa´ta) irreversible loss of hair associated with scarring, usually on the scalp.
congenital alopecia (alopecia congenita´lis) congenital absence of the scalp hair, which may occur alone or be part of a more widespread disorder.
alopecia limina´ris hair loss at the hairline along the front and back edges of the scalp.
male pattern alopecia see androgenetic a.
moth-eaten alopecia syphilitic alopecia involving the scalp and beard and occurring in small, irregular scattered patches, resulting in a moth-eaten appearance.
symptomatic alopecia (alopecia symptoma´tica) loss of hair due to systemic or psychogenic causes, such as general ill health, infections of the scalp or skin, nervousness, or a specific disease such as typhoid fever, or to stress. The hair may fall out in patches, or there may be diffuse loss of hair instead of complete baldness in one area.
alopecia tota´lis loss of hair from the entire scalp.
alopecia universa´lis loss of hair from the entire body.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

androgenetic alopecia

Progressive loss of scalp hair associated with increased sensitivity of hair follicles to androgens, thought to be caused by both genetic and environmental factors. It is more common and more severe in men (where it is referred to as "male pattern baldness" or "male pattern hair loss") than in women ("female pattern baldness" or "female pattern hair loss").
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

androgenetic alopecia

Hereditary thinning of hair induced by androgens in genetically susceptible men and women, which occurs in ± 50% of the general population between age 12 and 40.
Dihydrotestosterone binds to androgen receptors of susceptible scalp hair follicles, activating genes that gradually transform large terminal hair follicles to miniature follicles, producing finer hair in shorter hair cycles. Dihydrotestosterone is formed by peripheral conversion of testosterone by one of two isoforms of 5α-reductase, which, with other enzymes, regulate specific steroid transformations in skin. Those with AA have increased 5α-reductase, increased androgen receptors and decreased cytochrome P-450 aromatase, which converts testosterone to estradiol in hair follicles in the frontal scalp.
Finasteride, minoxidil.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

Androgenetic alopecia

Hair loss that develops into baldness and affects both men and women.
Mentioned in: Minoxidil
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.

Patient discussion about androgenetic alopecia

Q. Do you know if Propecia can truly stop hair loss and even grow back hair. do you have any statistics about it? do you know if there are any side effects to this medication?

A. it does work but there is some side affects, as in E.D. while you are on the med.

More discussions about androgenetic alopecia
This content is provided by iMedix and is subject to iMedix Terms. The Questions and Answers are not endorsed or recommended and are made available by patients, not doctors.
References in periodicals archive ?
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
The association of insulin resistance and metabolic syndrome in early androgenetic alopecia. Singapore Med J 2010; 51:931-6.
Currently, there are two medications that are FDA approved for androgenetic alopecia: minoxidil (Rogaine) and finasteride (Propecia).
The twice-daily 2% topical solution is the sole medication approved in the United States and Europe for female androgenetic alopecia.
Medically know as androgenetic alopecia, MPB affects two-thirds of all men by the age of 60.
(6) The program states that the Women's Androgenetic Alopecia Quality of Life (WAA-QOL) Questionnaire is useful in evaluating health-related quality of life specific to women.
It's called androgenetic alopecia and it's common in women with a strong family history of female hair thinning.
Recently, it was reported that EGCG might be useful in the prevention or treatment of androgenetic alopecia by selectively inhibiting 5[alpha]-reductase activity.
Androgenetic alopecia (AGA) is a dihydrotestosterone (DHT) mediated process, characterised by continuous miniaturisation of androgen reactive hair follicles and accompanied by perifollicular fibrosis of follicular units in histological examination (Yoo 2006).
Tokyo, Japan, May 30, 2006 - (JCN) - On May 29, Banyu Pharmaceutical announced that the results of its recent trial of Propecia, an agent for the treatment of androgenetic alopecia (AGA), have been published in the May 16 issue of Japanese Journal of Clinical Dermatology, an academic dermatology journal.
It is reported that one in three adult Japanese men are troubled by male pattern baldness, or androgenetic alopecia, which occurs during and after puberty.